Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5277522
Max Phase: Preclinical
Molecular Formula: C22H18ClN5O2S
Molecular Weight: 451.94
Associated Items:
ID: ALA5277522
Max Phase: Preclinical
Molecular Formula: C22H18ClN5O2S
Molecular Weight: 451.94
Associated Items:
Canonical SMILES: COc1ccc2c(c1)c(-c1cc(/N=C3/NC(=O)CS3)n(-c3cccc(Cl)c3)n1)cn2C
Standard InChI: InChI=1S/C22H18ClN5O2S/c1-27-11-17(16-9-15(30-2)6-7-19(16)27)18-10-20(24-22-25-21(29)12-31-22)28(26-18)14-5-3-4-13(23)8-14/h3-11H,12H2,1-2H3,(H,24,25,29)
Standard InChI Key: XZSKFJUZGDYTEC-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 451.94 | Molecular Weight (Monoisotopic): 451.0870 | AlogP: 4.54 | #Rotatable Bonds: 4 |
Polar Surface Area: 73.44 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.57 | CX Basic pKa: 0.84 | CX LogP: 4.76 | CX LogD: 4.54 |
Aromatic Rings: 4 | Heavy Atoms: 31 | QED Weighted: 0.49 | Np Likeness Score: -1.35 |
1. Soni JP, Chilvery S, Sharma A, Reddy GN, Godugu C, Shankaraiah N.. (2023) Design, synthesis and in vitro cytotoxicity evaluation of indolo-pyrazoles grafted with thiazolidinone as tubulin polymerization inhibitors., 14 (3): [PMID:36970141] [10.1039/d2md00442a] |
Source(1):